Original Research
Published on 04 Jan 2024
Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial
in Therapy in Gastroenterology
![Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial](https://www.frontiersin.org/files/myhome article library/1296048/1296048_Thumb_400.jpg)
- 8,591 views
- 2 citations